Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
ROCKVILLE, Md., March 30, 2023 (GLOBE NEWSWIRE) -- In a release published March 29, 2023 under the same headline by OpGen, Inc. (Nasdaq: OPGN), the financial tables were incorrect. The corrected...
-
Total revenue for 2022 was approximately $2.6 millionBalance sheet strengthened by recently closed public offering with gross proceeds of $7.5 millionConference call to be held March 29, 2023 at 4:30...
-
Approximately 5,000 sq. ft. facility houses laboratory and administrative operations under one location for future growth of businessARESdb, the company’s AMR knowledge database, has grown by 28% in...
-
NEW YORK, June 05, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Spero...
-
Dublin, April 14, 2022 (GLOBE NEWSWIRE) -- The "2021 Study of Women's Experiences with Urinary Tract Infections " report has been added to ResearchAndMarkets.com's offering. Usage of UTI at-home...
-
New York, March 30, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Silicone Based Catheters Market Forecast to 2028 - COVID-19 Impact and Global Analysis By...
-
NEW YORK, United States, Feb. 02, 2022 (GLOBE NEWSWIRE) -- Facts and Factors has published a new research report titled “Urinary Tract Infection Therapeutics Market- By Age Group (Children, Adults...
-
ORLANDO, Fla., Jan. 24, 2022 (GLOBE NEWSWIRE) -- Using national TV, radio, and web media campaigns, Microgen Diagnostics will be the first independent commercial lab in the U.S. to appeal directly...
-
CHICAGO, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Scripted (www.scripted.co) announced its new service to transform healthcare into an on-demand approach, where local pharmacists can prescribe and fill...
-
NEW YORK, Aug. 19, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Iterum Therapeutics plc (NASDAQ: ITRM) between November...